Diagnos Inc. issued new common shares to settle outstanding debt obligations. The Quebec-based company uses AI for early detection of eye-related health conditions. This financial maneuver cleans up the balance sheet but dilutes existing shareholders. It is a standard corporate restructuring move with little impact on the company's core technical AI development.